28 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
of our goals, aligned with shareholders’ interest and are worthy of shareholder support. Additional details concerning how we structure our … a discretionary bonus designed to drive the achievement of the Company’s strategic and corporate objectives. The goals are set at the start of the year
8-K
EX-10.1
b5e3 n4gzyudxlfpeqg
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
EX-99.1
33yhznqubhhi
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
8-K
EX-99.1
k1d95m0
3 May 22
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
6:11am
8-K
EX-99.1
gkahfra2f0zux2qe b4
3 Mar 22
Verona Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
6:06am
8-K
EX-99.1
ctn3fj9be
5 Jan 22
Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset
8:53am
8-K
EX-99.1
90ior2
9 Nov 21
Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
9:00am
8-K
EX-10.1
9aj0xp50 f1987b
11 Aug 21
Departure of Directors or Certain Officers
4:27pm
8-K
EX-99.1
i0917qdokfu5kn
5 Aug 21
Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:21pm
8-K
EX-99.1
xtmxak id
29 Apr 21
Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update
6:46am
DEF 14A
1wt4u 5hiflzg458l3
19 Mar 21
Definitive proxy
4:02pm
10-K
EX-10.20
yzxue2b8
25 Feb 21
Annual report
8:29am
8-K
EX-99.1
yxiep 239g1v7niqcd0
25 Feb 21
Verona Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
6:06am
6-K
EX-1.1
fuh3nx3h
25 Sep 20
Current report (foreign)
12:54pm
6-K
EX-1.1
je6il
14 Sep 20
Current report (foreign)
11:02am